Ultragenyx Pharmaceutical
RARE
RARE
163 hedge funds and large institutions have $2.01B invested in Ultragenyx Pharmaceutical in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 58 increasing their positions, 47 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
7% less capital invested
Capital invested by funds: $2.16B → $2.01B (-$158M)
38% less call options, than puts
Call options by funds: $5.25M | Put options by funds: $8.42M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
163
Holding in Top 10
–
Calls
$5.25M
Puts
$8.42M
Top Buyers
| 1 | +$41.5M | |
| 2 | +$40.4M | |
| 3 | +$32.9M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$31.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$23M |
Top Sellers
| 1 | -$27.3M | |
| 2 | -$18.5M | |
| 3 | -$18M | |
| 4 |
O
OppenheimerFunds
New York
|
-$17.7M |
| 5 |
CI
Capital International
Los Angeles,
California
|
-$9.49M |